Dr Reddys Laboratories Ltd Share Price Today - Live Blog for December 29, 2025

The share price of Dr Reddys Laboratories Ltd plunged by -0.13%, leaving investors concerned. At this moment, the stock can be acquired at 1267.70, but investors are assessing whether this is a temporary dip or a long-term trend.

Dr Reddys Laboratories Ltd witnessed a -0.13% decrease in its share price, and it is currently trading at 1267.70. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 18.4600, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd shares saw a -0.19% decrease, reaching a current market price of 1266.90. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 18.4600, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd's share price has fallen by -0.23%, presenting both challenges and opportunities for investors. As of now, it's trading at 1266.40, and market participants are assessing the implications. The stock has a PE ratio of 18.4600, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd's share price has fallen by -0.43%, presenting both challenges and opportunities for investors. As of now, it's trading at 1263.80, and market participants are assessing the implications. The stock has a PE ratio of 18.4600, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd witnessed a -0.45% drop in its share price and is currently trading at 1263.60. With the stock's PE at 18.4600 and the industry PE at 33.1403, investors are weighing their options.

The share price of Dr Reddys Laboratories Ltd experienced a -0.24% slump and is currently trading at 1266.20. While the stock maintains a PE ratio of 18.4600, the industry PE is 33.1403, raising questions about valuation.